Skip to content
Politically.com Search all
Menu

2026 · 2nd Quarter (Apr 1 - June 30)

NOVARTIS

Filed by MONUMENT ADVOCACY.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
2nd Quarter - Report
Posted
Jul 20, 2026
Income
$60,000.00
Expenses
Not reported
Client
NOVARTIS
Filing UUID
6a7cee7b-bc23-4dd5-bc0c-49809b3f55ac
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

Issues related to domestic healthcare and pricing; Issues related to cell, gene therapies, and radioligand therapies; Issues related to supply chain management, issues related to intellectual property; issues related to tariffs; issues related to ESRD; Most Favored Nation drug pricing policy

TRD · Trade (domestic/foreign)

Issues related to ongoing trade negotiations; Issues related to US/China relations; Issues related to international intellectual property; Issues related to global health; issues related to supply chain; and issues related to tariffs, issues related to ESRD.

TAX · Taxation/Internal Revenue Code

Issues related to US and international tax provisions; issues related to ESRD

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.